Psyence Signs Letter of Intent with Australian CRO iNGENū

2023-01-10T10:22:57+02:00January 9, 2023|Press Releases, Investor Information|

Psyence announce it has signed a Letter of Intent (LOI) with Contract Research Organisation (CRO) iNGENū to execute Psyence’s strategy of clinical development in palliative care. iNGENū is an Australian full-service CRO specialising in clinical trials for psychoactive pharmaceuticals.